@DAVE d u
Weve got backing from multiple studies showing the trial will be a success. Its the level of success which is the question. Without success in ph2a and MS and other studies ....no one would be here.
if we are to forward project the anticipated results... we should be at an mc worthy of a near marketable drug.
per-chart, page-420
-
- There are more pages in this discussion • 1,203 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
0.005(3.85%) |
Mkt cap ! $121.7M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 13.5¢ | 13.0¢ | $378.0K | 2.903M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5000 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 516956 | 4 |
View Market Depth
| Last trade - 16.10pm 15/10/2024 (20 minute delay) ? |
| PER (ASX) Chart |